Zusammenfassung: Diagnostik und Therapie bei systolischer Herzinsuffizienz, die sich an Leitlinien orientieren, senken die Letalit\u00e4t und Morbidit\u00e4t und verbessern Leistungsf\u00e4higkeit und Lebensqualit\u00e4t. Seit Mai 2012 liegt eine durch die Europ\u00e4ische Gesellschaft f\u00fcr Kardiologie aktualisierte Fassung der Leitlinie vor. Wichtige Neuerungen betreffen: Empfehlung von Ivabradin, Erweiterungen der Indikationen f\u00fcr Mineralokortikoid-Rezeptor-Antagonisten und f\u00fcr die kardiale Resynchronisationstherapie, revaskularisierende […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Diagnostik und Therapie bei systolischer Herzinsuffizienz, die sich an Leitlinien orientieren, senken die Letalit\u00e4t und Morbidit\u00e4t und verbessern Leistungsf\u00e4higkeit und Lebensqualit\u00e4t. Seit Mai 2012 liegt eine durch die Europ\u00e4ische Gesellschaft f\u00fcr Kardiologie aktualisierte Fassung der Leitlinie vor. Wichtige Neuerungen betreffen: Empfehlung von Ivabradin, Erweiterungen der Indikationen f\u00fcr Mineralokortikoid-Rezeptor-Antagonisten und f\u00fcr die kardiale Resynchronisationstherapie, revaskularisierende […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[130,1797,316,309,312,314,313,315,317,320,311,307,319,310,1798,1592,4449,4450,1633,3214,492,2975,2976,1362,180,4454,661,4456,1800,1803,1801,4455,537,1593,3217,4452,4458,4457,4453,4451,1804,4448,4447,306,2580,4446],"class_list":["post-2225","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-aicd","tag-angiotensin-ii-antagonisten","tag-angiotensin-ii-blocker","tag-angiotensin-ii-inhibitoren","tag-angiotensin-ii-rezeptor-antagonisten","tag-angiotensin-ii-rezeptor-blocker","tag-angiotensin-ii-rezeptor-inhibitoren","tag-at-ii-antagonisten","tag-at-ii-blocker","tag-at-ii-inhibitoren","tag-at-ii-rezeptor-antagonisten","tag-at-ii-rezeptor-blocker","tag-at-ii-rezeptor-inhibitoren","tag-automatischer-implantierbarer-kardioverter-defibrillator","tag-beautiful-studie","tag-bivad","tag-biventrikulaeres-assist-device","tag-bnp","tag-crt","tag-diuretika","tag-echokardiografie","tag-echokardiographie","tag-eplerenon","tag-herzinsuffizienz","tag-herztransplantation","tag-hydralazin","tag-i-preserve-studie","tag-icd","tag-implantate","tag-implantierbarer-defibrillator","tag-inh-studie","tag-isosorbiddinitrat","tag-ivabradin","tag-kardiale-resynchronisationstherapie","tag-linksventrikulaeres-assist-device","tag-lvad","tag-madit-crt-studie","tag-natriuretische-peptide","tag-nt-probnp","tag-ploetzlicher-herztod","tag-raft-studie","tag-saraten","tag-sartane","tag-shift-studie","tag-stich-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2225"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2225\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}